The Clorox Company Fundamental Analysis (NYSE: CLX)
The Clorox Company Fundamental Analysis (NYSE: CLX)
The Clorox Company (NYSE: CLX) shows weak financial fundamentals with a PE ratio of 16.66, profit margin of 8.74%, and ROE of -18.94%. The company generates $6.7B in annual revenue with weak year-over-year growth of 0.16%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -1878.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CLX's fundamental strength across five key dimensions:
Efficiency Score
WeakCLX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentCLX trades at attractive valuation levels.
Growth Score
WeakCLX faces weak or negative growth trends.
Financial Health Score
WeakCLX carries high financial risk with limited liquidity.
Profitability Score
WeakCLX struggles to sustain strong margins.
Key Financial Metrics
Is CLX Expensive or Cheap?
P/E Ratio
CLX trades at 16.66 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CLX's PEG of -0.63 indicates potential undervaluation.
Price to Book
The market values The Clorox Company at 108.62 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 4.70 times EBITDA. This is generally considered low.
How Well Does CLX Make Money?
Net Profit Margin
For every $100 in sales, The Clorox Company keeps $8.74 as profit after all expenses.
Operating Margin
Core operations generate 24.73 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-18.94 in profit for every $100 of shareholder equity.
ROA
The Clorox Company generates $7.53 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
The Clorox Company generates limited operating cash flow of $607.71M, signaling weaker underlying cash strength.
Free Cash Flow
The Clorox Company produces free cash flow of $402.16M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.33 in free cash annually.
FCF Yield
CLX converts 4.16% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
16.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.63
vs 25 benchmark
P/B Ratio
Price to book value ratio
108.62
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.44
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
61.33
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.66
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-18.94
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.33
vs 25 benchmark
How CLX Stacks Against Its Sector Peers
| Metric | CLX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 16.66 | 20.50 | Better (Cheaper) |
| ROE | -1893.55% | 633.00% | Weak |
| Net Margin | 8.74% | -2437.00% (disorted) | Weak |
| Debt/Equity | 61.33 | 0.79 | Weak (High Leverage) |
| Current Ratio | 0.66 | 2.32 | Weak Liquidity |
| ROA | 7.53% | 283.00% | Weak |
CLX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews The Clorox Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
7.67%
Industry Style: Defensive, Dividend, Low Volatility
GrowingEPS CAGR
-12.13%
Industry Style: Defensive, Dividend, Low Volatility
DecliningFCF CAGR
-35.36%
Industry Style: Defensive, Dividend, Low Volatility
Declining